CanniMed to source medical cannabis to Pharmasave
Aurora Cannabis Inc. and CanniMed Therapeutics Inc. announced this week that CanniMed has entered into a Letter of Intent to become a preferred supplier of medical cannabis to Pharmasave.
Pharmacy
NACDS commends CMS on new Medicare Part D policies
ARLINGTON, Va. – The National Association of Chain Drug Stores expressed appreciation to the Centers for Medicare and Medicaid Services (CMS) for provisions in the final 2019 Medicare Part D rule and in the 2019 Rate Announcement and Final Call Letter, which the agency released earlier this week.
Sanofi insulin savings program aims to cut costs
Sanofi’s new Insulins VALyou Savings Program will seek to help lower out-of-pocket costs for people living with diabetes who otherwise would pay full retail price for Lantus or Admelog.
CVS kept drug price growth almost flat for PBM clients in 2017
CVS Health has reported that, in 2017, the company kept drug price growth nearly flat for its pharmacy benefit management (PBM) clients, at a minimal 0.2%, despite manufacturer price inflation near 10%.
Walgreens supports Surgeon General’s advisory on opioids
Walgreens issued the following statement from president of operations Richard Ashworth in support of the advisory on naloxone and opioid overdose issued today by U.S. Surgeon General Jerome M. Adams.
NASP calls for continued Medicare drug pricing reforms
Earlier this week, the Centers for Medicare and Medicaid Services (CMS) issued a final Medicare Part D Rule and Part D Call Letter for calendar year 2019, taking a first step forward in an effort to expand access to more affordable drugs for seniors. Included in the rule are reforms that will seek
Giant Food pharmacists offer tips for allergy season
With allergy season upon us, the National Wildlife Federation estimates that the season now lasts 27 days longer, as a result of rising global temperatures.
Express Scripts names Ron Guerrier CIO
Express Scripts recently announced that Ron Guerrier will join the company as chief information officer, effective April 16, 2018.
Cardinal Health begins donation of 80,000 doses of Narcan
Today, as part of its Opioid Action Program, Cardinal Health began rolling out its donation of more than 80,000 doses of Narcan, (naloxone HCI) Nasal Spray 4mg, to community organizations who will distribute the life-saving overdose-reversal medication to first responders and law enforcement across
CVS to focus on kidney care and dialysis treatment
CVS Health announced an exciting new initiative that will focus on chronic kidney disease and dialysis and builds upon the company’s focus on driving innovation in the management of chronic disease to help improve patient health outcomes while managing costs.
PCMA responds to Medicare Part D ruling
Pharmaceutical Care Management Association (PCMA) president and chief executive officer Mark Merritt released the following statement on the Medicare Part D final rule released this week by the Department of Health and Human Services: “Two years ago drugmakers launched a campaign to deflect blame fo
Mylan to introduce new Symfi HIV treatment
Global pharmaceutical company Mylan N.V. recently announced that it will introduce in the U.S. a third cost-saving HIV combination. The U.S.
Cirillo named president at myMatrixx
Express Scripts Holding Company announced that Mike Cirillo has been named president of myMatrixx, an Express Scripts company. He will replace Artemis Emslie, who will stay with myMatrixx until the end of May to assist with the transition.
Five ways Amazon can jump into health care
Online retail giant Amazon will enter the broader health care market — it’s just a question of how, according to global management consulting firm L.E.K. Consulting. In a new report released yesterday, L.E.K.
GSK to buy out Novartis in consumer health joint venture
GlaxoSmithKline plc plans to buy Novartis’ 36.5% stake in their consumer health care joint venture for $13 billion. Under the agreement announced Tuesday, Novartis’ shares in the joint venture will be canceled, and the joint venture will pay the buyout price to Novartis.
Pharmacy groups hail expanded free Rx plan in Ontario
Canadian pharmacy organizations lauded the Ontario government’s expansion of its OHIP+ free prescriptions plan to seniors in the province. Ontario Premier Kathleen Wynne yesterday announced that, starting Aug.